Amgen, Inc. (AMGN)
443.84
+4.51
(+1.03%)
USD |
NASDAQ |
Aug 24, 16:00
444.00
+0.16
(+0.04%)
After-Hours: 20:00
Amgen Shareholders Equity (Quarterly) : 11.69B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.69B |
| March 31, 2026 | 9.19B |
| December 31, 2025 | 8.658B |
| September 30, 2025 | 9.619B |
| June 30, 2025 | 7.428B |
| March 31, 2025 | 6.207B |
| December 31, 2024 | 5.877B |
| September 30, 2024 | 7.527B |
| June 30, 2024 | 5.925B |
| March 31, 2024 | 5.022B |
| December 31, 2023 | 6.232B |
| September 30, 2023 | 7.656B |
| June 30, 2023 | 6.781B |
| March 31, 2023 | 5.348B |
| December 31, 2022 | 3.661B |
| September 30, 2022 | 3.653B |
| June 30, 2022 | 2.419B |
| March 31, 2022 | 916.00M |
| December 31, 2021 | 6.70B |
| September 30, 2021 | 8.217B |
| June 30, 2021 | 8.247B |
| March 31, 2021 | 9.334B |
| December 31, 2020 | 9.409B |
| September 30, 2020 | 10.96B |
| June 30, 2020 | 10.66B |
| Date | Value |
|---|---|
| March 31, 2020 | 9.485B |
| December 31, 2019 | 9.673B |
| September 30, 2019 | 10.93B |
| June 30, 2019 | 10.79B |
| March 31, 2019 | 10.83B |
| December 31, 2018 | 12.50B |
| September 30, 2018 | 14.35B |
| June 30, 2018 | 14.91B |
| March 31, 2018 | 15.62B |
| December 31, 2017 | 25.24B |
| September 30, 2017 | 32.23B |
| June 30, 2017 | 31.72B |
| March 31, 2017 | 30.64B |
| December 31, 2016 | 29.88B |
| September 30, 2016 | 30.77B |
| June 30, 2016 | 30.13B |
| March 31, 2016 | 28.68B |
| December 31, 2015 | 28.08B |
| September 30, 2015 | 27.97B |
| June 30, 2015 | 27.48B |
| March 31, 2015 | 26.51B |
| December 31, 2014 | 25.78B |
| September 30, 2014 | 25.32B |
| June 30, 2014 | 24.38B |
| March 31, 2014 | 22.74B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 11.83B |
| Regeneron Pharmaceuticals, Inc. | 31.71B |
| AbbVie, Inc. | -5.935B |
| Biogen, Inc. | 18.85B |
| Vertex Pharmaceuticals, Inc. | 20.25B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 95.64B |
| Total Liabilities (Quarterly) | 83.95B |
| Debt to Equity Ratio | 4.903 |
| Current Ratio | 1.371 |
| Net Debt Paydown Yield | 0.01% |